Feline coronavirus replication is affected by both cyclophilin A and cyclophilin B

References

1. Addie DD, Schaap IA, Nicolson L, Jarrett O. Persistence and transmission of natural type I feline coronavirus infection. J Gen Virol 2003; 84:2735–2744 [View Article][PubMed]
   [Google Scholar]
2. Perlman S, Netland J. Coronaviruses post-SARS: update on replication and pathogenesis. Nat Rev Microbiol 2009; 7:439–450 [View Article][PubMed]
   [Google Scholar]
3. Pedersen NC. A review of feline infectious peritonitis virus infection: 1963–2008. J Feline Med Surg 2009; 11:225–258 [View Article][PubMed]
   [Google Scholar]
4. Montali RJ, Strandberg JD. Extraperitoneal lesions in feline infectious peritonitis. Vet Pathol 1972; 9:109–121 [View Article][PubMed]
   [Google Scholar]
5. de Haan CA, Rottier PJ. Hosting the severe acute respiratory syndrome coronavirus: specific cell factors required for infection. Cell Microbiol 2006; 8:1211–1218 [View Article][PubMed]
   [Google Scholar]
6. Vogels MW, van Balkom BW, Kaloyanova DV, Batenburg JJ, Heck AJ et al. Identification of host factors involved in coronavirus replication by quantitative proteomics analysis. Proteomics 2011; 11:64–80 [View Article][PubMed]
   [Google Scholar]
7. Siekierka JJ, Hung SH, Poe M, Lin CS, Sigal NH. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature 1989; 341:755–757 [View Article][PubMed]
   [Google Scholar]
8. Takahashi N, Hayano T, Suzuki M. Peptidyl-prolyl cis–trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature 1989; 337:473–475 [View Article][PubMed]
   [Google Scholar]
9. de Wilde AH, Zevenhoven-Dobbe JC, van der Meer Y, Thiel V, Narayanan K et al. Cyclosporin A inhibits the replication of diverse coronaviruses. J Gen Virol 2011; 92:2542–2548 [View Article][PubMed]
   [Google Scholar]
10. Pfefferle S, Schöpf J, Kögl M, Friedel CC, Müller MA et al. The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors. PLoS Pathog 2011; 7:e1002331 [View Article][PubMed]
    [Google Scholar]
11. Tanaka Y, Sato Y, Osawa S, Inoue M, Tanaka S et al. Suppression of feline coronavirus replication in vitro by cyclosporin A. Vet Res 2012; 43:41 [View Article][PubMed]
    [Google Scholar]
12. von Brunn A, Ciesek S, von Brunn B, Carbajo-Lozoya J. Genetic deficiency and polymorphisms of cyclophilin A reveal its essential role for human coronavirus 229E replication. Curr Opin Virol 2015; 14:56–61 [View Article][PubMed]
    [Google Scholar]
13. Carbajo-Lozoya J, Müller MA, Kallies S, Thiel V, Drosten C et al. Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506. Virus Res 2012; 165:112–117 [View Article][PubMed]
    [Google Scholar]
14. Carbajo-Lozoya J, Ma-Lauer Y, Malešević M, Theuerkorn M, Kahlert V et al. Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including Alisporivir. Virus Res 2014; 184:44–53 [View Article][PubMed]
    [Google Scholar]
15. Spik G, Haendler B, Delmas O, Mariller C, Chamoux M et al. A novel secreted cyclophilin-like protein (SCYLP). J Biol Chem 1991; 266:10735–10738[PubMed]
    [Google Scholar]
16. Zydowsky LD, Etzkorn FA, Chang HY, Ferguson SB, Stolz LA et al. Active site mutants of human cyclophilin A separate peptidyl-prolyl isomerase activity from cyclosporin A binding and calcineurin inhibition. Protein Sci 1992; 1:1092–1099 [View Article][PubMed]
    [Google Scholar]
17. Carpentier M, Allain F, Haendler B, Denys A, Mariller C et al. Two distinct regions of cyclophilin B are involved in the recognition of a functional receptor and of glycosaminoglycans on T lymphocytes. J Biol Chem 1999; 274:10990–10998 [View Article][PubMed]
    [Google Scholar]
18. Tanaka Y, Amano A, Morisaki M, Sato Y, Sasaki T. Cellular peptidyl-prolyl cis/trans isomerase Pin1 facilitates replication of feline coronavirus. Antiviral Res 2016; 126:1–7 [View Article][PubMed]
    [Google Scholar]
19. Hopkins S, Gallay PA. The role of immunophilins in viral infection. Biochim Biophys Acta 2015; 1850:2103–2110 [View Article][PubMed]
    [Google Scholar]
20. Fischer G, Wittmann-Liebold B, Lang K, Kiefhaber T, Schmid FX. Cyclophilin and peptidyl-prolyl cis–trans isomerase are probably identical proteins. Nature 1989; 337:476–478 [View Article][PubMed]
    [Google Scholar]
21. Spencer KA, Hiscox JA. Characterisation of the RNA binding properties of the coronavirus infectious bronchitis virus nucleocapsid protein amino-terminal region. FEBS Lett 2006; 580:5993–5998 [View Article][PubMed]
    [Google Scholar]
22. Zúñiga S, Sola I, Moreno JL, Sabella P, Plana-Durán J et al. Coronavirus nucleocapsid protein is an RNA chaperone. Virology 2007; 357:215–227 [View Article][PubMed]
    [Google Scholar]
23. Zúñiga S, Cruz JL, Sola I, Mateos-Gómez PA, Palacio L et al. Coronavirus nucleocapsid protein facilitates template switching and is required for efficient transcription. J Virol 2010; 84:2169–2175 [View Article][PubMed]
    [Google Scholar]
24. Wu CH, Chen PJ, Yeh SH. Nucleocapsid phosphorylation and RNA helicase DDX1 recruitment enables coronavirus transition from discontinuous to continuous transcription. Cell Host Microbe 2014; 16:462–472 [View Article][PubMed]
    [Google Scholar]
25. Luo C, Luo H, Zheng S, Gui C, Yue L et al. Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A. Biochem Biophys Res Commun 2004; 321:557–565 [View Article][PubMed]
    [Google Scholar]
26. Carpentier M, Allain F, Haendler B, Slomianny MC, Spik G. Delineation of the calcineurin-interacting region of cyclophilin B. Protein Sci 2000; 9:2386–2393 [View Article][PubMed]
    [Google Scholar]
27. Yang F, Robotham JM, Nelson HB, Irsigler A, Kenworthy R et al. Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro. J Virol 2008; 82:5269–5278 [View Article][PubMed]
    [Google Scholar]